During the past decade, Azienda Ospedaliero-Universitaria Dipartimento Interaziendale Di Oncologia conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 10 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliero-Universitaria Dipartimento Interaziendale Di Oncologia" #1 collaborator was "AOU S.Orsola Malpighi-Unit of Oncologic Molecular and Transplantations Pathology" with 2 trials as a collaborator, "AOU S. Orsola Malpighi - Clinical Trial Office" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Bioikos Ambiente Srl" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliero-Universitaria Dipartimento Interaziendale Di Oncologia" are "Breast Cancer" (4 trials), "Bladder Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Colorectal Cancer" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Azienda Ospedaliero-Universitaria Dipartimento Interaziendale Di Oncologia" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliero-Universitaria Dipartimento Interaziendale Di Oncologia" are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (5 trials), "Docetaxel" (5 trials), "Paclitaxel" (5 trials), "Pertuzumab" (4 trials) and "Trastuzumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliero-Universitaria Dipartimento Interaziendale Di Oncologia" are 13 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Azienda Ospedaliero-Universitaria Dipartimento Interaziendale Di Oncologia". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Azienda Ospedaliero-Universitaria Dipartimento Interaziendale Di Oncologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliero-Universitaria Dipartimento Interaziendale Di Oncologia, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".